A Phase I/II Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics (Efficacy) of Chronic Twice-Daily Topical Monocular Application of INO-8875 Ophthalmic Formulation in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Trabodenoson (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions
- Sponsors Inotek Pharmaceuticals
- 11 Apr 2016 Results published in the Inotek Pharmaceuticals media release.
- 08 Oct 2013 New trial record